Skip to main content

Table 2 Overview of adverse events

From: Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire

 

Number of adverse events

Number of episodes

Incidence

Any adverse event

2545

1978

13.0% [12.5%; 13.6%]

Serious adverse events

105

100

0.7% [0.5%; 0.8%]

Severe adverse events

154

126

0.8% [0.7%; 1.0%]

Adverse events of special interest

3

3

<0.1%

Fatal serious adverse events

24

22

0.2% [0.1%; 0.2%]

Potentially ASAQ-related adverse events

929

837

5.5% [5.2%; 5.9%]

Adverse events requiring corrective treatment

157

105

0.7% [0.6%; 0.8%]